VFD

Olodanrigan

Find entries where: VFD

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	Olodanrigan
Synonyms	EMA401; (3S)-5-(benzyloxy)-2-(diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
Identifiers	(3~{S})-2-(2,2-diphenylethanoyl)-6-methoxy-5-phenylmethoxy-3,4-dihydro-1~{H}-isoquinoline-3-carboxylic acid
Formula	C₃₂ H₂₉ N O₅
Molecular Weight	507.576
Type	NON-POLYMER
Isomeric SMILES	COc1ccc2c(c1OCc3ccccc3)C[C@H](N(C2)C(=O)C(c4ccccc4)c5ccccc5)C(=O)O
InChI	InChI=1S/C32H29NO5/c1-37-28-18-17-25-20-33(31(34)29(23-13-7-3-8-14-23)24-15-9-4-10-16-24)27(32(35)36)19-26(25)30(28)38-21-22-11-5-2-6-12-22/h2-18,27,29H,19-21H2,1H3,(H,35,36)/t27-/m0/s1
InChIKey	GHBCIXGRCZIPNQ-MHZLTWQESA-N

Chemical Details
Formal Charge	0
Atom Count	67
Chiral Atom Count	1
Bond Count	71
Aromatic Bond Count	24

Drug Info: DrugBank

DrugBank ID	DB16266
Name	Olodanrigan
Groups	investigational
Description	Olodanrigan is under investigation in clinical trial NCT03297294 (Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)).
Synonyms	Olodanrigan
Categories	Benzene Derivatives Heterocyclic Compounds, Fused-Ring
CAS number	1316755-16-4

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Type-2 angiotensin II receptor	MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPIL...	unknown	antagonist

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682